These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18282707)

  • 1. Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
    Hernández AS; Swartz SG; Slusarchyk D; Yan M; Seethala RK; Sleph P; Grover G; Dickinson K; Giupponi L; Harper TW; Humphreys WG; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2067-72. PubMed ID: 18282707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagogues.
    Hernández AS; Cheng PT; Musial CM; Swartz SG; George RJ; Grover G; Slusarchyk D; Seethala RK; Smith M; Dickinson K; Giupponi L; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5928-33. PubMed ID: 17869100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).
    Li J; Chen SY; Li JJ; Wang H; Hernandez AS; Tao S; Musial CM; Qu F; Swartz S; Chao ST; Flynn N; Murphy BJ; Slusarchyk DA; Seethala R; Yan M; Sleph P; Grover G; Smith MA; Beehler B; Giupponi L; Dickinson KE; Zhang H; Humphreys WG; Patel BP; Schwinden M; Stouch T; Cheng PT; Biller SA; Ewing WR; Gordon D; Robl JA; Tino JA
    J Med Chem; 2007 Nov; 50(24):5890-3. PubMed ID: 17973363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-[3-Fluoro-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)phenyl]-4-methylpyridine: a highly potent and orally bioavailable metabotropic glutamate subtype 5 (mGlu5) receptor antagonist.
    Poon SF; Eastman BW; Chapman DF; Chung J; Cramer M; Holtz G; Cosford ND; Smith ND
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5477-80. PubMed ID: 15482907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of highly potent, selective, orally bioavailable, metabotropic glutamate subtype 5 (mGlu5) receptor antagonists devoid of cytochrome P450 1A2 inhibitory activity.
    Smith ND; Poon SF; Huang D; Green M; King C; Tehrani L; Roppe JR; Chung J; Chapman DP; Cramer M; Cosford ND
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5481-4. PubMed ID: 15482908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(2-[3-(pyridin-3-yloxy)phenyl]-2H-tetrazol-5-yl) pyridine: a highly potent, orally active, metabotropic glutamate subtype 5 (mGlu5) receptor antagonist.
    Huang D; Poon SF; Chapman DF; Chung J; Cramer M; Reger TS; Roppe JR; Tehrani L; Cosford ND; Smith ND
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5473-6. PubMed ID: 15482906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain.
    Li J; Chen SY; Tao S; Wang H; Li JJ; Swartz S; Musial C; Hernandez AA; Flynn N; Murphy BJ; Beehler B; Dickinson KE; Giupponi L; Grover G; Seethala R; Sleph P; Slusarchyk D; Yan M; Humphreys WG; Zhang H; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1825-9. PubMed ID: 18295486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrazole based amides as growth hormone secretagogues.
    Li JJ; Wang H; Li J; Qu F; Swartz SG; Hernández AS; Biller SA; Robl JA; Tino JA; Slusarchyk D; Seethala R; Sleph P; Yan M; Grover G; Flynn N; Murphy BJ; Gordon D
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2536-9. PubMed ID: 18378446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A potent, orally bioavailable benzazepinone growth hormone secretagogue.
    DeVita RJ; Bochis R; Frontier AJ; Kotliar A; Fisher MH; Schoen WR; Wyvratt MJ; Cheng K; Chan WW; Butler B; Jacks TM; Hickey GJ; Schleim KD; Leung K; Chen Z; Chiu SL; Feeney WP; Cunningham PK; Smith RG
    J Med Chem; 1998 May; 41(10):1716-28. PubMed ID: 9572898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-[2(R)-(2-amino-2-methylpropionylamino)-3-(1H-indol-3-yl)propionyl]- 3-benzylpiperidine-3(S)-carboxylic acid ethyl ester (L-163,540): a potent, orally bioavailable, and short-duration growth hormone secretagogue.
    Yang L; Morriello G; Patchett AA; Leung K; Jacks T; Cheng K; Schleim KD; Feeney W; Chan WW; Chiu SH; Smith RG
    J Med Chem; 1998 Jul; 41(14):2439-41. PubMed ID: 9651148
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.
    Trotter BW; Nanda KK; Kett NR; Regan CP; Lynch JJ; Stump GL; Kiss L; Wang J; Spencer RH; Kane SA; White RB; Zhang R; Anderson KD; Liverton NJ; McIntyre CJ; Beshore DC; Hartman GD; Dinsmore CJ
    J Med Chem; 2006 Nov; 49(24):6954-7. PubMed ID: 17125248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel orally active growth hormone secretagogues.
    Hansen TK; Ankersen M; Hansen BS; Raun K; Nielsen KK; Lau J; Peschke B; Lundt BF; Thøgersen H; Johansen NL; Madsen K; Andersen PH
    J Med Chem; 1998 Sep; 41(19):3705-14. PubMed ID: 9733496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological activity of 4-[(4-cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as potent and selective farnesyltransferase inhibitors.
    Wang L; Wang GT; Wang X; Tong Y; Sullivan G; Park D; Leonard NM; Li Q; Cohen J; Gu WZ; Zhang H; Bauch JL; Jakob CG; Hutchins CW; Stoll VS; Marsh K; Rosenberg SH; Sham HL; Lin NH
    J Med Chem; 2004 Jan; 47(3):612-26. PubMed ID: 14736242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of HIV-1 attachment. Part 9: an assessment of oral prodrug approaches to improve the plasma exposure of a tetrazole-containing derivative.
    Yeung KS; Qiu Z; Yang Z; Zadjura L; D'Arienzo CJ; Browning MR; Hansel S; Huang XS; Eggers BJ; Riccardi K; Lin PF; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2013 Jan; 23(1):209-12. PubMed ID: 23200244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new series of highly potent growth hormone-releasing peptides derived from ipamorelin.
    Ankersen M; Johansen NL; Madsen K; Hansen BS; Raun K; Nielsen KK; Thogersen H; Hansen TK; Peschke B; Lau J; Lundt BF; Andersen PH
    J Med Chem; 1998 Sep; 41(19):3699-704. PubMed ID: 9733495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent and orally active ET(A) selective antagonists with 5,7-diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acid structures.
    Yoshizumi T; Takahashi H; Ohtake N; Jona H; Sato Y; Kishino H; Sakamoto T; Ozaki S; Takahashi H; Shibata Y; Ishii Y; Saito M; Okada M; Hayama T; Nishikibe M
    Bioorg Med Chem; 2004 May; 12(9):2139-50. PubMed ID: 15080914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of 5-substituted 1H-tetrazoles by the copper-catalyzed [3+2] cycloaddition of nitriles and trimethylsilyl azide.
    Jin T; Kitahara F; Kamijo S; Yamamoto Y
    Chem Asian J; 2008 Sep; 3(8-9):1575-80. PubMed ID: 18561350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly potent growth hormone secretagogues.
    Lu Z; Tata JR; Cheng K; Wei L; Chan WW; Butler B; Schleim KD; Jacks TM; Hickey G; Patchett AA
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3657-9. PubMed ID: 17482461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (D)-2-tert-Butoxycarbonylamino-5,5-difluoro-5-phenyl-pentanoic acid: synthesis and incorporation into the growth hormone secretagogues.
    Li J; Chen SY; Murphy BJ; Flynn N; Seethala R; Slusarchyk D; Yan M; Sleph P; Zhang H; Humphreys WG; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4072-4. PubMed ID: 18554903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.
    Pinto DJ; Orwat MJ; Koch S; Rossi KA; Alexander RS; Smallwood A; Wong PC; Rendina AR; Luettgen JM; Knabb RM; He K; Xin B; Wexler RR; Lam PY
    J Med Chem; 2007 Nov; 50(22):5339-56. PubMed ID: 17914785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.